MK

Meenu Khaneja

Active Director Director DIN 00954670
DIN 00954670 First appointment Feb 2006 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Total affiliations 5 Since Feb 2006
Shareholding value •••• Premium profile

About Meenu Khaneja

Data last updated:

Meenu Khaneja is a Director at Radicon Laboratories Limited (since 2007), Director at Ambitree India Private Limited (since 2019) and Director at Shree Radhey Gobind Pharmaceuticals Private Limited (since 2012), and holds 2 more current directorships. The companies operate in Pharma and Wood. The 4 current companies with reported revenue have a combined latest revenue of ₹38.14 Cr; the largest is Radicon Laboratories Limited at ₹22.99 Cr (FY 2025).

DIN 00954670
Primary Designation Director
Industry Pharma
First Appointment 14 Feb 2006
Oldest Company Age 20 yrs
Largest company Radicon Laboratories Limited · ₹22.99 Cr (FY 2025)
Combined revenue ₹38.14 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Radicon Laboratories Limited U24232DL2007PLC158626
Director01 Feb 20072007₹22.99 Cr (FY 2025)Active
Ambitree India Private Limited U24290DL2019PTC349195
Director26 Apr 20192019₹6.75 Cr (FY 2024)Active
Director19 Dec 20122012₹6.63 Cr (FY 2025)Active
Director14 Feb 20062006₹1.77 Cr (FY 2022)Active
Director30 Nov 20232023Active

Directorship timeline

Open interactive timeline →
Shree Gobind Pharmaceuticals Private Limited
Radicon Laboratories Limited
Ambitree India Private Limited
Shree Radhey Gobind Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Meenu Khaneja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meenu Khaneja

Meenu Khaneja currently holds 5 directorships: Radicon Laboratories Limited (Director, since 01 Feb 2007, revenue ₹22.99 Cr (FY 2025)); Ambitree India Private Limited (Director, since 26 Apr 2019, revenue ₹6.75 Cr (FY 2024)); Shree Radhey Gobind Pharmaceuticals Private Limited (Director, since 19 Dec 2012, revenue ₹6.63 Cr (FY 2025)); Shree Gobind Pharmaceuticals Private Limited (Director, since 14 Feb 2006, revenue ₹1.77 Cr (FY 2022)); Kritajna Beauty World Private Limited (Director, since 30 Nov 2023).

Meenu Khaneja was first appointed on 14 Feb 2006 as Director at Shree Gobind Pharmaceuticals Private Limited. The most recent appointment on record is 30 Nov 2023 at Kritajna Beauty World Private Limited.

The 4 current companies of Meenu Khaneja that report revenue have a combined latest revenue of ₹38.14 Cr: Radicon Laboratories Limited ₹22.99 Cr (FY 2025); Ambitree India Private Limited ₹6.75 Cr (FY 2024); Shree Radhey Gobind Pharmaceuticals Private Limited ₹6.63 Cr (FY 2025); Shree Gobind Pharmaceuticals Private Limited ₹1.77 Cr (FY 2022).

The current boards of Meenu Khaneja's companies include Mahima Khaneja (Radicon Laboratories Limited), Sagar Khaneja (Radicon Laboratories Limited), Lakshay Khanna (Ambitree India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available